Ads
    Related conference
  1. Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
  2. Improvement of liver fibrosis verification using new minimally invasive markers in patients with chronic diffuse liver diseases
  3. PARAMETERS OF LIPID METABOLISM AND SEVERITY OF LIVER STEATOSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ON THE BACKGROUND OF HYPERTENSION DEPENDING ON THE STATUS OF CARBOHYDRATE METABOLISM
  4. BARD SCORING IN ASSESSING HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
  5. CHANGES IN LIPIDS IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE STAGE OF DECOMPENSATION
  6. The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis
  7. Opposite Effects of Metformin against Non-Alcoholic Fatty Liver Disease, Depend on Steatosis Grade
  8. EVALUATION OF LIVER FIBROSIS IN LIVER BIOPSY OF ALCOHOLIC LIVER DISEASE CASES, WITH RETICULIN STAIN AND CD31 IMMUNOSTAIN
  9. ESTIMATION OF LIPID PROFILE AND GLYCEMIC STATUS AND LIVER ENZYMES, AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
  10. Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease